Literature DB >> 11069873

Depression in medical illness: the role of the immune system.

R Yirmiya1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11069873      PMCID： PMC1071158          DOI： 10.1136/ewjm.173.5.333

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  20 in total

1.  Psychological variables as predictors of rubella antibody titers and fatigue--a prospective, double blind study.

Authors:  M Morag; A Morag; A Reichenberg; B Lerer; R Yirmiya
Journal:  J Psychiatr Res       Date:  1999 Sep-Oct       Impact factor: 4.791

2.  Attentional and mnemonic deficits associated with infectious disease in humans.

Authors:  L Capuron; D Lamarque; R Dantzer; G Goodall
Journal:  Psychol Med       Date:  1999-03       Impact factor: 7.723

3.  Antidepressant pharmacotherapy of depression associated with multiple sclerosis.

Authors:  R B Schiffer; N M Wineman
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

Review 4.  Psychoneuroimmunology: interactions between the nervous system and the immune system.

Authors:  R Ader; N Cohen; D Felten
Journal:  Lancet       Date:  1995-01-14       Impact factor: 79.321

5.  Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion.

Authors:  M Maes; C Song; A H Lin; S Bonaccorso; G Kenis; R De Jongh; E Bosmans; S Scharpé
Journal:  Neuropsychopharmacology       Date:  1999-04       Impact factor: 7.853

Review 6.  Cytokines and depression: fortuitous or causative association?

Authors:  R Dantzer; E Wollman; L Vitkovic; R Yirmiya
Journal:  Mol Psychiatry       Date:  1999-07       Impact factor: 15.992

Review 7.  Depression and chronic medical illness.

Authors:  W Katon; M D Sullivan
Journal:  J Clin Psychiatry       Date:  1990-06       Impact factor: 4.384

8.  Cytokine-associated emotional and cognitive disturbances in humans.

Authors:  A Reichenberg; R Yirmiya; A Schuld; T Kraus; M Haack; A Morag; T Pollmächer
Journal:  Arch Gen Psychiatry       Date:  2001-05

9.  Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  J Clin Psychiatry       Date:  1994-10       Impact factor: 4.384

10.  Fluoxetine treatment of depression caused by interferon-alpha.

Authors:  J L Levenson; H J Fallon
Journal:  Am J Gastroenterol       Date:  1993-05       Impact factor: 10.864
View more
  19 in total

1.  Depression, cytokines, and pancreatic cancer.

Authors:  William Breitbart; Barry Rosenfeld; Kristen Tobias; Hayley Pessin; Geoffrey Y Ku; Jianda Yuan; Jedd Wolchok
Journal:  Psychooncology       Date:  2013-10-18       Impact factor: 3.894

Review 2.  Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: a systematic review.

Authors:  Andrew McCombie; Richard Gearry; Jane Andrews; Antonina Mikocka-Walus; Roger Mulder
Journal:  J Clin Psychol Med Settings       Date:  2015-03

3.  Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.

Authors:  Jennifer C Felger; Li Li; Paul J Marvar; Bobbi J Woolwine; David G Harrison; Charles L Raison; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2012-10-13       Impact factor: 7.217

Review 4.  Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Authors:  Jennifer C Felger; Andrew H Miller
Journal:  Front Neuroendocrinol       Date:  2012-09-21       Impact factor: 8.606

5.  Duloxetine Protects Human Neuroblastoma Cells from Oxidative Stress-Induced Cell Death Through Akt/Nrf-2/HO-1 Pathway.

Authors:  Daiane Fátima Engel; Jade de Oliveira; Vicente Lieberknecht; Ana Lucia Severo Rodrigues; Andreza Fabro de Bem; Nelson Horácio Gabilan
Journal:  Neurochem Res       Date:  2017-11-13       Impact factor: 3.996

Review 6.  Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

Authors:  Helena M Abelaira; Gislaine Z Réus; Fabricia Petronilho; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

7.  Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.

Authors:  François Frenois; Maïté Moreau; Jason O'Connor; Marc Lawson; Charlotte Micon; Jacques Lestage; Keith W Kelley; Robert Dantzer; Nathalie Castanon
Journal:  Psychoneuroendocrinology       Date:  2007-05-04       Impact factor: 4.905

8.  Psychoneuroimmune implications of type 2 diabetes: redux.

Authors:  Jason C O'Connor; Daniel R Johnson; Gregory G Freund
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

Review 9.  Toll-Like Receptor Signaling in Depression.

Authors:  Leandra K Figueroa-Hall; Martin P Paulus; Jonathan Savitz
Journal:  Psychoneuroendocrinology       Date:  2020-09-01       Impact factor: 4.905

10.  Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients.

Authors:  Jian-tong Jiao; Jun Sun; Jian-fen Ma; Min-chao Dai; Jin Huang; Chen Jiang; Cheng Wang; Chao Cheng; Jun-fei Shao
Journal:  J Neurooncol       Date:  2015-07-28       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.